# Glucocorticoids in COVID-19 (CORTIVID)

> **NCT04438980** · PHASE3 · COMPLETED · sponsor: **Fundacion Miguel Servet** · enrollment: 72 (actual)

## Conditions studied

- Covid-19 Pneumonia

## Interventions

- **DRUG:** Methylprednisolone
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04438980
- **Lead sponsor:** Fundacion Miguel Servet
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-15
- **Primary completion:** 2021-03-12
- **Final completion:** 2021-04-09
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2021-05-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04438980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04438980, "Glucocorticoids in COVID-19 (CORTIVID)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04438980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*